Eleven new recommendations were issued to address appropriate HER2 testing and clinical guidance in individuals with advanced gastroesophageal adenocarcinoma.
The company's technology will be used to analyze samples from a large cohort of Chinese volunteers to identify biomarkers for early cancer detection.
In PNAS this week: gene mutations linked to gastric cancer development, genetic determinants that influence reward processing, and more.
The three organizations are inviting comment from health professionals on the recommendations.
Along with breast, ovarian, and pancreatic cancers, the "signature 3" mutation pattern was detected in around 10 percent of sequenced gastric tumors.
In PNAS this week: regenerative flatworm genome, transmission patterns of autism-linked de novo mutations, and more.
The researchers used a method known as paired-end tag sequencing, or DNA-PET, to identify five recurrent gene fusions in Asian populations with gastric cancer.
New loss-of-function mutations in a gene called ATM were implicated in gastric cancer risk, based on genotyping profiles for thousands of gastric cancer cases and controls in Iceland.
The research also uncovered other mutations that might be associated with these cancers in patients who do not have a CDH1 mutation.
The non-invasive, blood-based circulating tumor cell and circulating tumor DNA cancer tests will be made available to 19 million patients.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.